APA (7th ed.) Citation

Devogelaer, J., Sambrook, P., Reid, D. M., Goemaere, S., Ish-Shalom, S., Collette, J., . . . Reginster, J. (2013). Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids. Rheumatology (Oxford, England), 52(6), 1058-1069. https://doi.org/10.1093/rheumatology/kes410

Chicago Style (17th ed.) Citation

Devogelaer, J.-P, et al. "Effect on Bone Turnover Markers of Once-yearly Intravenous Infusion of Zoledronic Acid Versus Daily Oral Risedronate in Patients Treated with Glucocorticoids." Rheumatology (Oxford, England) 52, no. 6 (2013): 1058-1069. https://doi.org/10.1093/rheumatology/kes410.

MLA (9th ed.) Citation

Devogelaer, J.-P, et al. "Effect on Bone Turnover Markers of Once-yearly Intravenous Infusion of Zoledronic Acid Versus Daily Oral Risedronate in Patients Treated with Glucocorticoids." Rheumatology (Oxford, England), vol. 52, no. 6, 2013, pp. 1058-1069, https://doi.org/10.1093/rheumatology/kes410.